Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

Title:	Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
Authors:	Willis, Michael^{Aff1, IDs1330002000968x_cor1}; Nilsson, Andreas^Aff1; Kellerborg, Klas^Aff1; Ball, Philip^Aff2; Roe, Rupert^Aff3; Traina, Shana^Aff4; Beale, Rebecca^Aff5; Newell, Isabelle^Aff5
Source:	Diabetes Therapy: Research, treatment and education of diabetes and related disorders. 12(1):313-328
Database:	Springer Nature Journals